Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join the growing global community and consortia of Olink users to empower your biomarker discovery.
Over 3,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
PLOS ONE, 2022Genetically regulated gene expression and proteins revealed discordant effects
Pott J., Garcia T., Hauck S. et al.
Olink Target 96
PROTEOMICS, 2022Stability and reproducibility of proteomic profiles in epidemiological studies: comparing the Olink and SOMAscan platforms
Haslam D., Li J., Dillon S. et al.
eBioMedicine, 2022The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study
Jones D., Wetten A., Barron-Millar B. et al.
European Journal of Heart Failure, 2022Distinct pathophysiological pathways in women and men with heart failure
Ravera A., Santema B., de Boer R. et al.
Clinical Kidney Journal, 2022Kidney oxygenation, perfusion and blood flow in people with and without type 1 diabetes
Laursen J., Søndergaard-Heinrich N., Haddock B. et al.
Pediatric Research, 2022Validation of disease-specific biomarkers for the early detection of bronchopulmonary dysplasia
Kindt A., Förster K., Cochius-den Otter S. et al.
eBioMedicine, 2022Higher levels of Bifidobacteria and tumor necrosis factor in children with drug-resistant epilepsy are associated with anti-seizure response to the ketogenic diet
Dahlin M., Singleton S., David J. et al.
Journal of Nephrology, 2022Assay-related differences in SuPAR levels: implications for measurement and data interpretation
Vasbinder A., Raffield L., Gao Y. et al.
Frontiers in Immunology, 2022The Genetic Risk for COVID-19 Severity Is Associated With Defective Immune Responses
Kuijpers Y., Chu X., Jaeger M. et al.
Clinical and Translational Medicine, 2022Proteomic profiling of lung diffusion impairment in the recovery stage of SARS‐CoV‐2–induced ARDS
García‐Hidalgo M., González J., Benítez I. et al.
Nature Communications, 2022Contribution of rare whole-genome sequencing variants to plasma protein levels and the missing heritability
Kierczak M., Rafati N., Höglund J. et al.
Scandinavian Journal of Pain, 2022Association between systemic inflammation and experimental pain sensitivity in subjects with pain and painless neuropathy after traumatic nerve injuries
Miclescu A., Granlund P., Butler S. et al.
The Journal of Infectious Diseases, 2022Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy
Kolossváry M., deFilippi C., Lu M. et al.
Journal of Cardiovascular Translational Research, 2022Investigation into the Health Effects of Reduced Chymase Function Using Predicted Loss-of-Function Mutations in CMA1
Fairhurst-Hunter Z., Walters R., Zink A. et al.
Communications Biology, 2022Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction
Nayar S., Pontarini E., Campos J. et al.
Proteomes, 2022Insights on Proteomics-Driven Body Fluid-Based Biomarkers of Cervical Cancer
Mukherjee A., Pednekar C., Kolke S. et al.
PROTEOMICS – Clinical Applications, 2022Clinical applications of plasma proteomics and peptidomics: Towards precision medicine
He B., Huang Z., Huang C. et al.
Biochemical and Biophysical Research Communications, 2022A pilot study using proximity extension assay of cerebrospinal fluid and its extracellular vesicles identifies novel amyotrophic lateral sclerosis biomarker candidates
Sjoqvist S., Otake K.
Cell, 2022Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation
Wei T., Chandy M., Nishiga M. et al.
Translational Psychiatry, 2022Metabolomics analysis of post-traumatic stress disorder symptoms in World Trade Center responders
Kuan P., Yang X., Kotov R. et al.
3026 publications
Items per page
1301-1320 of 3026 publications